(Total Views: 670)
Posted On: 12/26/2020 10:52:06 PM
Post# of 145254
Our interim results were harvested by the DSMC at mid term of the trial. They were complete and had a 28 day end point. That information was available before we completed the trial it would seem. Maybe the FDA based their decision on our first half of the phase 3 trial. Those results would show better since standard of care improved over the coarse of the trial the last 6 months.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)